Quince Therapeutics, Inc. - COM (QNCX)

Q4 2022 13F Holders as of 12/31/2022

Type / Class
Equity / COM
Number of holders
45
Total Shares
5.39M
Shares change
-3.71M
Total reported value, excl. options
$3.43M
Value change
-$3.31M
Put/Call ratio
0.08
Number of buys
12
Number of sells
-36
Price
$0.64
Investor Option Weight % Change % Value $ * Price $ Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.